Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,580.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,<,20.0,1.0,>,29.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1454.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,74.0,1.0,=,19.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1582.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,267.0,1.0,=,5.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2180.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,200.0,1.0,=,10.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2340.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,1023.0,1.0,=,2.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2881.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,833.0,1.0,=,3.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,608.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,85.0,1.0,=,7.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,625.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,184.0,1.0,=,3.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,893.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,132.0,1.0,=,6.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,912.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,181.0,1.0,=,5.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1177.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,82.0,1.0,=,14.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1190.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,402.0,1.0,=,3.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1309.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,185.0,1.0,=,7.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1357.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,200.0,1.0,=,6.8